Continuous Apomorphine infusion

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	5

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04887467 (ClinicalTrials.gov)	September 16, 2021	26/4/2021	Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuousand Diurnal Subcut ...	Pharmacokinetic Study of Continuousand Diurnal Subcutaneous Apomorphine Infusionin Patients With Par ...	Parkinson Disease	Drug: Apomorphine	Rennes University Hospital	NULL	Recruiting	50 Years	70 Years	Male	20	Phase 4	France
2	NCT02702076 (ClinicalTrials.gov)	May 2017	2/3/2016	Apomorphine in Parkinson's Disease Patients With Visual Hallucinations	Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of ContinuousSubcutaneou ...	Parkinson's Disease;Hallucinations, Visual	Drug: Apomorphine;Drug: Placebo	University Medical Center Groningen	NULL	Recruiting	30 Years	N/A	All	35	Phase 2	Netherlands
3	EUCTR2016-000102-11-NL (EUCTR)	23/11/2016	08/11/2016	Trial to evaluate the efficacy of continuoussubcutaneous apomorphine infusionin Parkinson’s disease ...	Randomized, double-blind, placebo-controlled trial to evaluate the efficacy of continuoussubcutaneou ...	Parkinson's disease patients with refractory visual hallucinations MedDRA version: 19.0;Level: PT;Cl ...	Trade Name: APO-go Product Name: Apomorphine	University Medical Center Groningen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2;Phase 3	Netherlands
4	NCT02339064 (ClinicalTrials.gov)	February 2015	31/3/2014	Infusion of Apomorphine: Long-term Safety Study	A Phase 3, Open-Label Study of the Safety, Efficacy and Tolerability of ApomorphineAdministered by C ...	Idiopathic Parkinson's Disease	Drug: apomorphine infusion	US WorldMeds LLC	NULL	Active, not recruiting	30 Years	N/A	All	99	Phase 3	United States
5	NCT01039090 (ClinicalTrials.gov)	February 2009	22/12/2009	Efficacy of Continuous Apomorphine Infusionon Cognitive and Neuropsychological Functions in Parkinso ...	Prospective, Randomised, Comparative Study Comparing Efficacy of Continuous Apomorphine InfusionVers ...	Parkinsons's Disease	Drug: Continuous Apomorphine infusion;Drug: Usual dopaminergic per os treatment	Rennes University Hospital	NULL	Completed	18 Years	N/A	All	21	Phase 3	France

First Previous1Next Last